Ara
Toplam kayıt 35, listelenen: 21-30
Change in PsAID-12 scores in patients continuing or discontinuing anti-TNF treatments in psoriatic arthritis: results from the HUR-BIO biologic registry
(Springer, 2019-01-21)
Objective
Psoriatic Arthritis Impact of Disease 12-item questionnaire (PsAID-12) has been developed to be used in psoriatic arthritis in daily practice. The aim of the present study was to assess the change values of ...
Which Definition Should be used to Determine Colchicine Resistance Among Patients with Familial Mediterranean Fever?
(Clin Exp Rheumatol, 2018-11-12)
Objectives: Colchicine is the main therapy for familial Mediterranean fever (FMF); however, 5-10% of patients are colchicine-resistant. There is no standard and validated definition for colchicine resistance. We aimed to ...
Adalimumab as Treatment for Venous Thrombosis in Behçet's Syndrome: Comment on the Article by Emmi et al
(Wıley, 2019-03-02)
We read with interest the article by Emmi et al 1 regarding the effect of adalimumab (ADA)–based treatment versus disease‐modifying antirheumatic drug (DMARD) therapy for venous thrombosis in Behçet's syndrome (BS). Their ...
Capillaroscopic findings in Turkish Takayasu arteritis patients
(TÜBİTAK, 2019-10-24)
Abstract
Background/aim: Abnormal capillaroscopic findings have been reported in vasculitic syndromes such as Behçet’s disease, Henoch–Schönlein purpura, and Wegener’s granulomatosis. This study was conducted to define ...
Correction to: Proposal for a simple algorithm to differentiate adult-onset Still's disease with other fever of unknown origin causes: a longitudinal prospective study
(Springer, 2019-04-01)
The author regrets that the original version of this article contained error. Figure 1 was shown in the wrong version, thus corrected figure is shown in this article.
Some concerns from Turkey
(BMJ, 2018-11-24)
We read the paper written by Kaneko et al with great interest.1 This study demonstrates the safety and efficacy of tocilizumab in patients with adult-onset Still’s disease (AOSD). This randomised placebo-controlled study ...
Oral ulcer activity assessment with the composite index according to different treatment modalities in Behçet's syndrome: a multicentre study
(Clin Exp Rheumatol, 2019-12-09)
Objectives: The aim of this multicentre study was to understand patients' needs and to evaluate the oral ulcer activity with the Composite Index (CI), according to different treatment modalities in Behçet's syndrome ...
Predictive factors for work-day loss in Behçet's syndrome: A multi-center study
(Wiley, 2020-02-23)
Objective: The aim of this multi-center study was to assess predictive factors for work-day loss as an indirect cost element in Behçet's syndrome (BS).
Methods: In this cross-sectional, multi-center study, 834 BS patients ...
Polyarteritis nodosa: lessons from 25 years of experience
(Clin Exp Rheumatol, 2018-10-30)
Objectives: Polyarteritis nodosa is a necrotising vasculitis of predominantly medium size vessels. The present study aimed to summarise the characteristics of PAN patients, and also analyse the trend of decreasing PAN ...
Behçet Disease With Vascular Involvement
(2015)
Vascular involvement is one of the major causes of mortality and morbidity in Behçet disease (BD). There are no controlled studies for the management of vascular BD (VBD), and according to the EULAR recommendations, only ...